{
"NDC": {
"NDCCode": "72205-098-72",
"PackageDescription": "473 mL in 1 BOTTLE (72205-098-72) ",
"NDC11Code": "72205-0098-72",
"ProductNDC": "72205-098",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Pyridostigmine Bromide",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Pyridostigmine Bromide",
"DosageFormName": "SOLUTION",
"RouteName": "ORAL",
"StartMarketingDate": "20230921",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA216512",
"LabelerName": "Novadoz Pharmaceuticals LLC",
"SubstanceName": "PYRIDOSTIGMINE BROMIDE",
"StrengthNumber": "60",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2023-10-07",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20230926",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}